BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, December 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 1, 2002
View Archived Issues
CuraGen, Bayer Advance Four Compounds Through Screening
One year after signing a $1.4 billion agreement aimed at developing 12 drugs in obesity and diabetes, CuraGen Corp. and partner Bayer Corp. said they have successfully completed screening against four targets. (BioWorld Today)
Read More
ViaCell Files For $115M IPO To Fund Clinical Trials, R&D
Read More
One Unfertilized Egg From Single Female Primate Donor Produced Broad Spectrum Of Progeny Cells
Read More
Digene Raises $15M Through Stock Sale To Acqua Wellington
Read More
AltaRex Reanalyzes OvaRex IIb Results, Reaches Significance
Read More
Other News To Note
Read More
Appointments And Advancements
Read More